A61K 38/1741
Alpha-glycoproteins
Official title: {alpha-Glycoproteins}
A61K38/1741 (Alpha-glycoproteins) appears on 67 US grants and 139 published applications in this corpus.
Search patents in A61K- Granted patents
- 67
- Published applications
- 139
- Assignees
- 61
- Inventors
- 156
- Latest grant
- 29 Oct 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 1 |
| 2002 | 0 | 0 |
| 2003 | 0 | 1 |
| 2004 | 2 | 2 |
| 2005 | 0 | 4 |
| 2006 | 0 | 3 |
| 2007 | 4 | 13 |
| 2008 | 3 | 1 |
| 2009 | 1 | 1 |
| 2010 | 0 | 4 |
| 2011 | 0 | 0 |
| 2012 | 1 | 0 |
| 2013 | 1 | 12 |
| 2014 | 11 | 12 |
| 2015 | 4 | 10 |
| 2016 | 4 | 5 |
| 2017 | 1 | 7 |
| 2018 | 4 | 10 |
| 2019 | 5 | 10 |
| 2020 | 6 | 10 |
| 2021 | 8 | 9 |
| 2022 | 1 | 7 |
| 2023 | 5 | 4 |
| 2024 | 4 | 5 |
| 2025 | 0 | 3 |
| 2026 | 0 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions for treating pathological calcification conditions, and methods using same29 Oct 2024US 12,128,087 B2Yale University
- Glyco-engineered immunization antigens2 Jul 2024US 12,023,373 B2Expres2ion Biotechnologies ApS
- Artificial exosome composition and related methods2 Jul 2024US 12,023,407 B2University of Massachusetts
- Application of skeletal muscle secreted factor THBS4 in preparation of drug for improving systemic glucose and lipid metabolism30 Apr 2024US 11,969,457 B2Institute of Microbiology, Guangdong Academy of Sciences (Guangdong Detection Center of Microbiology
- Methods and compositions for treating, inhibiting, and/or preventing heterotopic ossification26 Dec 2023US 11,851,490 B2Northwestern University
- Methods of increasing sialic acid levels in recombinant glycosylated proteins8 Oct 2026US 2026/0308601 A1Denali Therapeutics Inc.
- Therapeutic protein combinations30 Jul 2026US 2026/0216286 A1Ohio State Innovation Foundation
- Oligonucleotide encoding a tissue inhibitor of metalloproteases protein for medical use in mammals7 May 2026US 2026/0124231 A1
- Calsequestrin-based metal ion reactive particle and uses thereof30 Apr 2026US 2026/0115299 A1ToolBio. Co
- Macrophage polarizing oncolytic herpes simplex virus for cancer therapy9 Apr 2026US 2026/0097088 A1Research Institute At Nationwide Children's Hospital
Most cited
By later US patents
- Methods and compositions for regenerating tissue24US 7,563,459 B2The United States of America as represented by the Department of Vetrans Affairs · 2009
- Methods and compositions for directing cells to target organs17US 7,282,222 B2The United States of America as represented by the Department of Veterans Affairs · 2007
- Compositions for treating pathological calcification conditions, and methods using same15US 10,064,917 B2Yale Unviersity · 2018
- Compositions for treating pathological calcification conditions, and methods using same15US 10,517,927 B2Yale University · 2019
- Proteins for cancer cell specific induction of apoptosis and method for isolation thereof15US 5,994,298 A1999